Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic/Pharmacodynamic Study of the PassPort(R) Transdermal Insulin Delivery System in Type 1 Diabetes Patients

NCT00519623 is registered in ClinicalTrials.gov with Altea Therapeutics as lead sponsor.

NCT NCT00519623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00519623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic/Pharmacodynamic Study of the PassPort(R) Transdermal Insulin Delivery System in Type 1 Diabetes Patients
Lead sponsor
Altea Therapeutics
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2007
Completion date
December 31, 2007
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes